1.Orthodontic treatment of malocclusions by lower incisor extraction
Yinzhong DUAN ; Juju ZHANG ; Shi LI
Journal of Practical Stomatology 1996;0(02):-
Objective:To investigate the indications of lower incisor extraction in orthodontic treatment of malocclusions. Methods:42 patients (males 16,females 26) were divided into four groups: abnormal Bolton index; class III malocclusions with anterior teeth cross bite; one congenital lower incisor losing; and anterior teeth area periodontal disease.One lower incisor extraction, one lower incisor and other teeth extraction and other accessorial therapy were used in the treatment. Results:According to these four different conditions, alternative treatment plans of lower incisor extraction should be determined. For the former two conditions, one lower incisor was extracted; A lower incisor and two maxillary first premolars were extracted in the third condition, in which lower canines and first premolars should be grinded to improve esthetics; In the last condition, some maxillary teeth need stripping besides extracting one lower incisor. All of the 42 cases achieved satisfactory results, normal overbite and overjet and stable occlusal relationship. Conclusion:To be well acquainted with the indications of the extraction of the lower incisor in orthodontic treatment of malocclusions can help to achieve satisfactory clinical effect.
2.Clinical Research on Near-term Quality of Life among Unstable Angina Patients by Shen-Yuan Yi-Qi Huo-Xue Capsule Combined with Early Percutaneous Coronary Intervention
Fuyong CHU ; Hongxu LIU ; Dawei ZHANG ; Jiaxing CHEN ; Juju SHANG ; Zhuhua ZHANG ; Qi ZHOU ; Aiyong LI ; Wei TIAN
World Science and Technology-Modernization of Traditional Chinese Medicine 2014;(12):2593-2597
This study was aimed to investigate the effects of Shen-Y uan Y i-Qi Huo-Xue (SYYQHX) capsule com-bined with early percutaneous coronary intervention (PCI) on near-term quality of life (QOL) in unstable angina (UA) patients. Seventy-eight patients diagnosed with UA were selected and randomly divided into the treatment group and control group, with 39 patients in each group. Early PCI was undergone after coronary angiography. Before PCI, the control group was given routine western medication. The treatment group was given routine western medication plus SYYQHX capsule, three pills once, three times daily. The treatment lasted for 30 days. The QOL scores were evalu-ated among patients from both groups before and after treatment in order to determine the efficacy on angina, electro-cardiogram (ECG) and traditional Chinese medicine (TCM) main symptom. The results showed that compared to pre-treatment, the scores of physical limitation (PL), angina stability (AS), angina frequency (AF), and treatment satisfac-tion ( TS ) were significantly increased after treatment ( P < 0 . 05 ) . Compared with the control group , after treat-ment with SYYQHX capsule, the AF, duration time and symptoms of palpitation, fatigue and shortness of breath were obviously improved (P< 0.05). The scores of AS, AF and TS in the treatment group were significantly increased (P < 0.05). It was concluded that SYYQHX capsule combined with early PCI can improve the near-term QOL and TCM main symptoms among UA patients.
3.Discussion on the substance basis and possible mechanism of Xiefei Lishui Prescription in the treatment of heart failure based on UPLC-Q-TOF-MS combined with network pharmacology
Shuaijie GUO ; Sinai LI ; Weihong LIU ; Lei ZHANG ; Juju SHANG ; Hongxu LIU ; Mingxue ZHOU
International Journal of Traditional Chinese Medicine 2024;46(3):345-352
Objective:To explore the effective components and potential mechanisms of Xiefei Lishui Prescription in the treatment of heart failure.Methods:Ultra high-performance liquid chromatography tandem four stage rod time of flight mass spectrometry (UPLC-Q-TOF-MS) technology was used to analyze and identify the active components of Xiefei Lishui Prescription. Drug targets were predicted through the Swiss Target Prediction database, and disease targets were collected from Gene Cards, Dis GENET, and TTD databases. The intersection of drug targets and disease targets was screened using a STRING database for protein interaction to identify core targets. The core targets were included in the DAVID database for GO enrichment and KEGG analysis. Finally, molecular docking validation was performed between the drug components and the corresponding core targets.Results:The results identified 10 active components of Xiefei Lishui Prescription, and 8 potential active components were screened using network pharmacology for the treatment of heart failure with Xiefei Lishui Prescription, corresponding to 160 related action targets. A total of 1 305 disease-related targets were collected, and a total of 51 targets ad 17 core targets were included in the string database for protein interaction analysis. GO functional enrichment and KEGG analysis indicated that the mechanism of Xiefei Lishui Prescription in treating heart failure may be related to pathways such as protein binding, ATP binding, and negative regulation of the VEGF signaling pathway and T cell receptor pathway during apoptosis. The molecular docking results showed that baicalin exhibited good binding activity with ESR1, sorghum isoflavones with ESR1, and quercetin with AKT1, EGFR, IL2, and ABCB1.Conclusion:Xiefei Lishui Prescription may exert therapeutic effects on heart failure through multiple pathways by targeting ESR1, AKT1, EGFR, and other targets.
4. Pathogen spectrum of viral encephalitis in children living in Hebei province, China from May to December 2017
Tao FAN ; Yanjie HAN ; Ruiqin ZHANG ; Panhui YU ; Li ZHAO ; Juju QI ; Xinna LI ; Ruihuan WANG ; Yishuo SUN ; Jian ZHAO ; Chuanze HU ; Ji WANG ; Suzhen SUN ; Xuejun MA
Chinese Journal of Experimental and Clinical Virology 2019;33(3):275-279
Objective:
To investigate the pathogenic characteristics of viral encephalitis in children living in Hebei province.
Methods:
We randomly collected cerebrospinal fluid specimens from a total of 399 children diagnosed with viral encephalitis in Hebei Children′s Hospital from May to December 2017. Real-time fluorescence quantitative PCR and Sanger sequencing were used to detect viral nucleic acids in cerebrospinal fluid by an automatic laboratory station. Statistical analysis was performed on the experimental data using SPSS 21.0 software and the clinical data were analyzed. Comparison of infection rates of EV encephalitis in different months, using line × column chi-square test. The MRI and EEG positive rates of different viral encephalitis and viral encephalitis patients not infected with the virus were analyzed by Fisher′s exact probability test. The positive rate of infection with different viruses and non-virus agents was analyzed by Fisher′s exact probability test.
Results:
The result showed that 80 of 399 samples were positive, and the positive rate was 20.05%. It included 22 cases of enterovirus, 4 cases of influenza A virus, 3 cases of mumps virus, 2 cases of herpes simplex virus type 1, 1 case of herpes simplex virus type 2, 4 cases of EB virus, 7 cases of cytomegalovirus, 7 cases of herpes zoster virus, 8 cases of adenovirus, 14 cases of human herpesvirus type 6. Eight cases had combined viral infection. Eight cases had concurrent infections: 3 cases had enterovirus and herpesvirus type 6 concurrent infection, 1 case had enterovirus and Japanese encephalitis virus concurrent infection and 1 case had herpes simplex virus type 2 and adenovirus, 1 case had influenza A virus herpesvirus type 6, 1 case had mumps virus and herpesvirus type 6, 1 case had mumps virus and herpesvirus type 6, 1 case had herpes simplex virus type 1 and herpes zoster virus concurrent infections. Children with EV viral encephalitis in Hebei Province were highly prevalent in May and June (